Background: Research concerning the link between individual vascular risk factors and cognition is plentiful but few studies have investigated the role of global vascular risk.
Introduction
Cardiovascular (CV) disease is a major public health challenge in the western world, likely to worsen with the increasing prevalence of obesity and type 2 diabetes [1] . Owing to common mechanistic pathways, a growing body of evidence supports a role of CV risk factors in cognitive decline etiology [2] [3] [4] .
Over the past few decades, multicomponent CV risk scores based on the Framingham Risk equations and accounting for joint effects have been elaborated in order to predict CV events and to characterize CV profiles in a quantitative manner [5] . According to a recent metaanalysis, interventions using such validated scores to identify high-risk individuals may help decrease CV morbidity and mortality risk [6] .
Recent clinical research using quantitative MRI reported an inverse association between total cerebral brain volume ratio and Stoke Risk Profile, while a positive association was observed between total cerebral brain volume ratio and cognitive function [7] . there is a large heterogeneity in the neuropsychological tests employed, which limits the possibility to compare the respective studies [8] . Accordingly, researchers have underlined the need to summarize individual cognitive scores via multidimensional techniques (principal component analysis, PCA; factor analysis) and to use such summary cognitive scores as primary outcomes-rather than only investigating performances on specific tests [2] .
The aims of the present study were to estimate the cross-time association between different Framingham risk scores assessed in midlife using accurate data and subsequent poor performance in large sample. Accounting for previously reported limitations, we focused on 5 different cognitive domains characterized by summary scores, and we test if the associations differed by the risk profile score used accounting for follow-up bias.
Materials and methods

Population
The SU.VI.MAX study (SUpplémentation en VItamines et Minéraux AntioXydants, 1994 AntioXydants, -2002 ) was a randomized, double-blind, placebo-controlled primary prevention trial including 12,741 individuals for a planned follow-up of 8 years. It tested the efficacy of daily nutritional-dose supplementation with antioxidant vitamins and minerals (ascorbic acid, vitamin E, β-carotene, selenium, zinc) on the incidence of cancer, CV morbidity and overall mortality [18] . 
Selection of the sample
From the 6,850 participants in the SU.VI.MAX 2 study, we excluded women < 45 years at baseline (n=1,267) to obtain a similar age range across genders, those with missing neuropsychological data (n=1,136), with missing data for Framingham risk profile computation (n=891) or with missing covariate data (n=295). The final sample included 3,261 participants. 
Data collection
In 2007-2009, all participants were invited to undergo a clinical examination and (in a subsample) a neuropsychological evaluation by trained neuropsychologists. Episodic memory was evaluated using the RI-48 delayed cued recall test based on a list of 48 words belonging to 12 different categories. This test was designed to limit "ceiling effects" encountered in some list-learning tests. The total score was the number of words retrieved (maximum score of 48) [20] . Lexical-semantic memory was assessed by verbal fluency tasks, including a semantic fluency task (naming as many animals as possible), and a phonemic fluency task (citing words beginning with the letter P). The total score was the number of correct words produced during a 2-min period for each task [21] . Working memory was assessed with the forward and backward digit span. Participants were asked to repeat two sequences of digits, forwards or backwards. The number of digits increased by one until the participant failed two consecutive trials of the same digit span. One point was scored for each correct sequence repeated, with a maximum score of 14 points for digit span forward as well as backward.
Mental flexibility was assessed through the Delis-Kaplan trail-making test (TMT) [22] , consisting of connecting numbers and letters alternating between the two series. The score was the time in seconds needed to complete the task [23] . We thus reverse-coded this score so that higher scores would correspond to better performance, and further log-transformed it to improve normality. The cognitive test scores were converted into T scores (mean=50, SD=10). A composite cognitive score was defined as the mean of the standardized test scores
Moreover, principal component analysis (PCA) with orthogonal rotation was performed in order to yield summary scores accounting for correlations among the cognitive tests as previously outlined [19] . Briefly stated, PCA factors are linear combinations of the initial variables (the cognitive test scores in our case) that explain a maximum of the variancecovariance structure of these initial variables.
Habitually, PCA-factors are named after those initial variables with which they have the strongest correlations.
The extracted factors as well as the composite cognitive score were rescaled to have an SD of 10.
In order to account for multiple comparisons, results were hierarchically interpreted. We defined the composite cognitive score and the extracted PCA-factors as our main outcomes, and scores on the TMT (reflecting mental flexibility) as secondary outcome. Mental flexibility appeared to be of major interest in the context of our study as it presents a key domain of executive function, and previous studies argue for a role of the FSRP in subsequent executive functioning [7;9;10;13].
We defined the extracted PCA-factors as our main outcomes, but also investigated the specific association between mental flexibility (measured by the TMT in our study), a key domain of executive function and the risk profile scores, as previous studies argue for a role of the FSRP in subsequent executive functioning [7;9;10;13].
At baseline, information on sex, age, smoking (never, former, current smoker), alcohol use (g/day), physical activity (irregular, <1 h walking/day, 1 h walking/day), occupation (employees/office work, manual workers, homemakers/unemployed, white collar), education (primary, secondary, university level), self-reported medication use and self-reported memory troubles ["Do you have any memory complaints?" (yes/no)] was collected by questionnaires.
At the first clinical examination (1995) (1996) , anthropometric measurements were collected.
Blood pressure (BP) was measured using a standardized procedure with a mercury sphygmomanometer. It was taken once from each arm following a 10-min rest. The mean of 8 these two measurements was used for analyses. Blood samples were obtained after a 12-h fast, and all biochemical measurements were centralized.
The following biochemical indicators were measured at baseline: Fasting blood glucose, serum triglycerides and serum total cholesterol (Advia 1650 autoanalyzer; Bayer Diagnostics, Puteaux, France), as well as serum apolipoprotein B (nephelemetric assay, BNA Behring).
HDL-cholesterol was calculated from total cholesterol and apolipoprotein B, using Planella (1994) (1995) (1996) [28]. The Framingham risk scores include baseline age, sex, systolic BP, HDL-cholesterol, total cholesterol, smoking (current versus former or never), and diabetes with specific weight. Left ventricular hypertrophy was not available in our sample, thus this parameter was not accounted for.
Framingham risk scores aim to predict 10-year probability of developing coronary heart disease, stroke and CV disease. Higher scores have been designed to be associated with a higher risk of new events.
Risk scores were divided into quartiles (Q1-Q4) for analysis and standardized continuous scores were also computed.
Included and excluded participants were compared using the chi² test or Wilcoxon rank test, as appropriate.
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Descriptive baseline characteristics are reported as mean SD) or percentages by sex as equations are different for men and women. Reported P-values refer to non-parametric Wilcoxon test or to the chi² test, as appropriate.
Logistic regression was used to model the odds ratio (OR) and 95% confidence interval (CI) of poor cognitive performance (i.e., scoring 10th percentile on the cognitive assessment allowing to use OR as reliable proxy of relative risk) across Framingham risk score Q, using the lowest category as reference. P for trend was assessed, using linear contrast tests across the categories. OR of poor cognitive performance according to Framingham risk scores modeled as continuous variables (after standardization) were also estimated, i.e. for an increase of 1 SD of each risk score.
In the initial model, analyses were adjusted for age and sex. In the second model, analyses were adjusted for follow-up time (year), age at neuropsychological examination (year), sex and education (primary, secondary and post-secondary).
In the third set of models, analyses were further adjusted for occupation (employees manual workers, homemakers/ unemployed, white collar), intervention group (active group or placebo) during the trial phase (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) , baseline alcohol consumption (g/d), baseline physical activity (irregular, <1h/day, ≥1 h /day), depressive symptoms (continuous score ranging from 0 to 60) concomitant with the cognitive evaluation, and baseline self-reported memory troubles (yes/no).
As an attempt to partly correct for selection bias, analyses were carried out using inverse probability weighting [29] . The probability of being included in the study was determined using baseline characteristics, including sociodemographic, lifestyle (alcohol, diet, physical activity) and health variables as well as interaction terms, among the original cohort after removing women younger than 45 years (N=10,090). The C statistic of the final model was 0.69 and the quality of the model was estimated through published recommendations (P-value of the square of logit of the predicted value added in the model, Hosmer-Lemeshow test, absence of zero fitted probability in both included and excluded participants, comparison of the sum of the 10% highest weights in included participants to half of the total sum of weight)
[29].
Data were analyzed using the inverse probability of inclusion as the respective weight.
To compare the predictive values of the different risk scores on cognition, we used the area under the receiver operating characteristic curves (AUC) [30] . AUC comparisons were fit using the SAS %add_predictive macro.
Effect modification by gender and antihypertensive treatment was also tested. Sensitivity analyses were also performed after excluding participant developing stroke during the followup (N=39).
In secondary analysis, covariance analyses were used to estimate the difference in mean cognitive scores (95% confidence interval, CI) with similar adjustment strategy for composite cognitive score, verbal memory score and working memory score.
All tests of statistical significance were two-sided and the type I error was set at 5%.
Statistical analyses were performed using SAS software (version 9.3, SAS Institute Inc, Cary, NC, USA).
Results
Among SU.VI.MAX participants > 45y at baseline (N=10,090), subjects excluded from the current study were more likely to be women, younger, more often smokers, with lower levels of education, less physically active. They also exhibited higher total cholesterol and fasting glucose concentration and higher systolic blood pressure. Excluded participants performed worse on some cognitive tests, i.e. digit span, and showed higher depressive symptoms (Supplemental table 1).
Participants were 65.5 (SD=4.6) years old at the neuropsychological evaluation. Mean followup was 13.4 (SD=0.6) years.
Characteristics of participants by sex are shown in Table 1 . Men reported higher education, higher alcohol intake, were less likely to report memory troubles at baseline or depressive symptoms at follow-up, and were more physically active than were women. They also had higher BMI, BP, glycemia, total and LDL-cholesterol and lower HDL-cholesterol at baseline than did women. Men were also more often smokers (current and former). Considering these continuous-scale standardized risk scores, all three risk profiles were significantly and negatively associated with global cognitive impairment and most specifically with poor performance in verbal memory, even after adjustment for confounders.
AUC analysis (supplemental Table 1 ) revealed no differences in the prediction of poor cognitive performance according to risk score (All P >0.05).
Findings from the secondary analysis testing for the associations between Framingham risk profiles (FCHDRP, FCVDRP and FSRP) in Q and subsequent poor cognitive performances are presented in Table 3 . Findings were similar to those of the primary analysis. All the Framingham risk profiles (FCHDRP, FCVDRP and FSRP) were negatively associated with verbal memory performances.
Discussion
Using a large sample of aging adults, this study showed a significant long-term role of all three Framingham CV midlife risk profiles in poor cognitive performance during aging, particularly in the domain of verbal memory. These findings persisted after accounting for many confounders, especially non-modifiable risk factors such as sex and age. Computing of area under the ROC curve argue for interchangeability of midlife risk scores in relationship with subsequent cognitive function.
Such scores, easily computable from non-invasive data, are great interest in clinical practice to identify very early population at elevated risk in poor cognitive performance in aging.
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Besides, improvement of modifiable factors may help in maintaining cognitive performance in aging.
For comparison purposes, we modeled these three scores, reflecting heart disease, CV disease and stroke risk, as continuous variables. These scores were similarly associated with poor performance in the verbal memory domain. However, stroke risk, when modeled in Q, was less strongly associated with cognitive impairment than were the other two risk scores, which could be partly explained by the fact that stroke risk in our population was low, with small variability.
Only one study reported association between heart disease risk profile (FCHDRP) and and preventing the assessment of cognitive decline. Given the design of our study, caution is needed when generalizing the findings, as participants were relatively healthy volunteers involved in a long-term nutritional study [38] . An over selection of our sample may also occur as participants in the SU.VI.MAX 2 study are those who accepted to pursue the follow-up at the end of the SU.VI.MAX study. In turn these participants are also more likely to be health conscious.
Moreover, residual confounding cannot be excluded, despite the extensive adjustment for confounders and bias due to non-response or missing data may be an issue in our study but has been limited as we used inverse probability weighting.
In turn, our study also exhibits strengths and other original aspects including its large sample of community-dwelling subjects, long follow-up (focusing on midlife exposure) and the use of validated and sensitive tools designed to assess various cognitive domains while limiting floor/ceiling effects.
In conclusion, our findings from an initially middle-aged and CV disease-free population provide new insights regarding the role of stroke risk profiles but also regarding general CV risk profiles in cognition. From a public health viewpoint, these risk scores may also help identify and target at-risk individuals, thus strengthening public health efforts aimed at cognitive function preservation.
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